ANDA 88892, held by Superpharm. Prednisolone.
As of Nov 15, 2026, ANDA 88892 (Prednisolone), held by Superpharm, was first approved by FDA on Feb 26, 1985, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone5MG ยท tablet;oral | Prednisolone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
